Related references
Note: Only part of the references are listed.ALK7 Acts as a Positive Regulator of Macrophage Activation through Down-Regulation of PPARγ Expression
Wen-Lin Cheng et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2021)
Foam cell origination from degenerated vascular smooth muscle cells in atherosclerosis: An ultrastructural study on hyperlipidemic rabbits
Yong-Xin Ru et al.
ULTRASTRUCTURAL PATHOLOGY (2020)
WISP1 alleviates lipid deposition in macrophages via the PPARγ/CD36 pathway in the plaque formation of atherosclerosis
Dian Liu et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2020)
Grape seed proanthocyanidins suppressed macrophage foam cell formation by miRNA-9 via targeting ACAT1 in THP-1 cells
Dongyan Shao et al.
FOOD & FUNCTION (2020)
Peroxisome proliferator-activated receptor A/G reprogrammes metabolism associated with lipid accumulation in macrophages
Guozhu Ye et al.
METABOLOMICS (2019)
PPARα and PPARγ activation attenuates total free fatty acid and triglyceride accumulation in macrophages via the inhibition of Fatp1 expression
Guozhu Ye et al.
CELL DEATH & DISEASE (2019)
ATP-Binding Cassette Transporter A Subfamily 8 Is a Sinusoidal Efflux Transporter for Cholesterol and Taurocholate in Mouse and Human Liver
Kazunari Sasaki et al.
MOLECULAR PHARMACEUTICS (2018)
Homocysteine accelerates atherosclerosis via inhibiting LXR alpha-mediated ABCA1/ABCG1-dependent cholesterol efflux from macrophages
Ping Jin et al.
LIFE SCIENCES (2018)
Molecular basis activation of lecithin: cholesterol acyltransferase by a compound that increases HDL cholesterol
Kelly A. Manthei et al.
ELIFE (2018)
Infectious Agents in Atherosclerotic Cardiovascular Diseases through Oxidative Stress
Marisa Di Pietro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Mechanisms of foam cell formation in atherosclerosis
Dimitry A. Chistiakov et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2017)
ROS via BTK-p300-STAT1-PPARγ signaling activation mediates cholesterol crystals-induced CD36 expression and foam cell formation
Sivareddy Kotla et al.
REDOX BIOLOGY (2017)
Peroxisome Proliferator-Activated Receptor (PPAR) Gamma Agonists as Therapeutic Agents for Cardiovascular Disorders: Focus on Atherosclerosis
Ekaterina A. Ivanova et al.
CURRENT PHARMACEUTICAL DESIGN (2017)
Macrophage-mediated cholesterol handling in atherosclerosis
Dimitry A. Chistiakov et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
Inhibition of Macrophage CD36 Expression and Cellular Oxidized Low Density Lipoprotein (oxLDL) Accumulation by Tamoxifen: A PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR (PPAR)-DEPENDENT MECHANISM
Miao Yu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Signaling events in pathogen-induced macrophage foam cell formation
Yazdani B. Shaik-Dasthagirisaheb et al.
PATHOGENS AND DISEASE (2016)
Helicobacter pylori-An Infectious Risk Factor for Atherosclerosis?
Cong He et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2014)
Effect of peroxisome proliferator-activated receptor γ on the cholesterol efflux of peritoneal macrophages in inflammation
Kun He et al.
MOLECULAR MEDICINE REPORTS (2014)
MAPK-PPARα/γ signal transduction pathways are involved in Chlamydia pneumoniae-induced macrophage-derived foam cell formation
Bei Cheng et al.
MICROBIAL PATHOGENESIS (2014)
Persistent C. pneumoniae infection in atherosclerotic lesions: rethinking the clinical trials
Lee Ann Campbell et al.
FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY (2014)
Arctigenin promotes cholesterol efflux from THP-1 macrophages through PPAR-γ/LXR-α signaling pathway
Xiaolin Xu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Ombuin-3-O-β-D-glucopyranoside from Gynostemma pentaphyllum is a dual agonistic ligand of peroxisome proliferator-activated receptors α and δ/β
Mastura Abd Malek et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2013)
Foam cells in atherosclerosis
Xiao-Hua Yu et al.
CLINICA CHIMICA ACTA (2013)
Anti-atherosclerotic potential of gossypetin via inhibiting LDL oxidation and foam cell formation
Jing-Hsien Chen et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2013)
Activation of Peroxisome Proliferator-Activated Receptor δ Inhibits Human Macrophage Foam Cell Formation and the Inflammatory Response Induced by Very Low-Density Lipoprotein
Lazar A. Bojic et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Effect of the steroid receptor antagonist RU486 (mifepristone) on an IFNγ-induced persistent Chlamydophila pneumoniae infection model in epithelial HEp-2 cells
Kasumi Ishida et al.
JOURNAL OF INFECTION AND CHEMOTHERAPY (2012)
Increased stability of phosphatase and tensin homolog by intermedin leading to scavenger receptor A inhibition of macrophages reduces atherosclerosis in apolipoprotein E-deficient mice
Xiao-Yan Dai et al.
JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2012)
Mechanism of Action of a Peroxisome Proliferator-Activated Receptor (PPAR)-δ Agonist on Lipoprotein Metabolism in Dyslipidemic Subjects with Central Obesity
Esther M. M. Ooi et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
13-hydroxy linoleic acid increases expression of the cholesterol transporters ABCA1, ABCG1 and SR-BI and stimulates apoA-I-dependent cholesterol efflux in RAW264.7 macrophages
Ines Kaemmerer et al.
LIPIDS IN HEALTH AND DISEASE (2011)
Pathogens and atherosclerosis: Update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis
Michael E. Rosenfeld et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Regulation of ABCG1 expression in human keratinocytes and murine epidermis
Yan J. Jiang et al.
JOURNAL OF LIPID RESEARCH (2010)
Ghrelin inhibits foam cell formation via simultaneously down-regulating the expression of acyl-coenzyme A:cholesterol acyltransferase 1 and up-regulating adenosine triphosphate-binding cassette transporter A1
Bei Cheng et al.
CARDIOVASCULAR PATHOLOGY (2009)
CD36 and macrophages in atherosclerosis
Sophie Collot-Teixeira et al.
CARDIOVASCULAR RESEARCH (2007)
Dual promoter structure of mouse and human fatty acid translocase/CD36 genes and unique transcriptional activation by peroxisome proliferator-activated receptor α and γ ligands
O Sato et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
The role of PPAR-gamma in macrophage differentiation and cholesterol uptake
KJ Moore et al.
NATURE MEDICINE (2001)
Identification of periodontal pathogens in atheromatous plaques
VI Haraszthy et al.
JOURNAL OF PERIODONTOLOGY (2000)
The possible role of human cytomegalovirus (HCMV) in the origin of atherosclerosis
R Horváth et al.
JOURNAL OF CLINICAL VIROLOGY (2000)
Share Paper
